Global Gastrointestinal Therapeutics Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Gastrointestinal Therapeutics Revenue
1.4 Market by Type
1.4.1 Global Gastrointestinal Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Oral
1.4.3 Parenteral
1.5 Market by Application
1.5.1 Global Gastrointestinal Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 IBD
1.5.3 Irritable Bowel Syndrome (IBS)
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Gastrointestinal Therapeutics Market Perspective (2015-2026)
2.2 Global Gastrointestinal Therapeutics Growth Trends by Regions
2.2.1 Gastrointestinal Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Gastrointestinal Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Gastrointestinal Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 Gastrointestinal Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Gastrointestinal Therapeutics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Gastrointestinal Therapeutics Players by Market Size
3.1.1 Global Top Gastrointestinal Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Gastrointestinal Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Gastrointestinal Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Gastrointestinal Therapeutics Market Concentration Ratio
3.2.1 Global Gastrointestinal Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Gastrointestinal Therapeutics Revenue in 2019
3.3 Gastrointestinal Therapeutics Key Players Head office and Area Served
3.4 Key Players Gastrointestinal Therapeutics Product Solution and Service
3.5 Date of Enter into Gastrointestinal Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Gastrointestinal Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Gastrointestinal Therapeutics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Gastrointestinal Therapeutics Market Size by Application (2015-2020)
5.2 Global Gastrointestinal Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Gastrointestinal Therapeutics Market Size (2015-2020)
6.2 Gastrointestinal Therapeutics Key Players in North America (2019-2020)
6.3 North America Gastrointestinal Therapeutics Market Size by Type (2015-2020)
6.4 North America Gastrointestinal Therapeutics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Gastrointestinal Therapeutics Market Size (2015-2020)
7.2 Gastrointestinal Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Gastrointestinal Therapeutics Market Size by Type (2015-2020)
7.4 Europe Gastrointestinal Therapeutics Market Size by Application (2015-2020)
8 China
8.1 China Gastrointestinal Therapeutics Market Size (2015-2020)
8.2 Gastrointestinal Therapeutics Key Players in China (2019-2020)
8.3 China Gastrointestinal Therapeutics Market Size by Type (2015-2020)
8.4 China Gastrointestinal Therapeutics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Gastrointestinal Therapeutics Market Size (2015-2020)
9.2 Gastrointestinal Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Gastrointestinal Therapeutics Market Size by Type (2015-2020)
9.4 Japan Gastrointestinal Therapeutics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Gastrointestinal Therapeutics Market Size (2015-2020)
10.2 Gastrointestinal Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Gastrointestinal Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Gastrointestinal Therapeutics Market Size by Application (2015-2020)
11 India
11.1 India Gastrointestinal Therapeutics Market Size (2015-2020)
11.2 Gastrointestinal Therapeutics Key Players in India (2019-2020)
11.3 India Gastrointestinal Therapeutics Market Size by Type (2015-2020)
11.4 India Gastrointestinal Therapeutics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Gastrointestinal Therapeutics Market Size (2015-2020)
12.2 Gastrointestinal Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Gastrointestinal Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Gastrointestinal Therapeutics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 AbbVie
13.1.1 AbbVie Company Details
13.1.2 AbbVie Business Overview
13.1.3 AbbVie Gastrointestinal Therapeutics Introduction
13.1.4 AbbVie Revenue in Gastrointestinal Therapeutics Business (2015-2020))
13.1.5 AbbVie Recent Development
13.2 Allergan
13.2.1 Allergan Company Details
13.2.2 Allergan Business Overview
13.2.3 Allergan Gastrointestinal Therapeutics Introduction
13.2.4 Allergan Revenue in Gastrointestinal Therapeutics Business (2015-2020)
13.2.5 Allergan Recent Development
13.3 Johnson & Johnson
13.3.1 Johnson & Johnson Company Details
13.3.2 Johnson & Johnson Business Overview
13.3.3 Johnson & Johnson Gastrointestinal Therapeutics Introduction
13.3.4 Johnson & Johnson Revenue in Gastrointestinal Therapeutics Business (2015-2020)
13.3.5 Johnson & Johnson Recent Development
13.4 Takeda
13.4.1 Takeda Company Details
13.4.2 Takeda Business Overview
13.4.3 Takeda Gastrointestinal Therapeutics Introduction
13.4.4 Takeda Revenue in Gastrointestinal Therapeutics Business (2015-2020)
13.4.5 Takeda Recent Development
13.5 Novartis
13.5.1 Novartis Company Details
13.5.2 Novartis Business Overview
13.5.3 Novartis Gastrointestinal Therapeutics Introduction
13.5.4 Novartis Revenue in Gastrointestinal Therapeutics Business (2015-2020)
13.5.5 Novartis Recent Development
13.6 Pfizer
13.6.1 Pfizer Company Details
13.6.2 Pfizer Business Overview
13.6.3 Pfizer Gastrointestinal Therapeutics Introduction
13.6.4 Pfizer Revenue in Gastrointestinal Therapeutics Business (2015-2020)
13.6.5 Pfizer Recent Development
13.7 Merck
13.7.1 Merck Company Details
13.7.2 Merck Business Overview
13.7.3 Merck Gastrointestinal Therapeutics Introduction
13.7.4 Merck Revenue in Gastrointestinal Therapeutics Business (2015-2020)
13.7.5 Merck Recent Development
13.8 F. Hoffmann-La Roche
13.8.1 F. Hoffmann-La Roche Company Details
13.8.2 F. Hoffmann-La Roche Business Overview
13.8.3 F. Hoffmann-La Roche Gastrointestinal Therapeutics Introduction
13.8.4 F. Hoffmann-La Roche Revenue in Gastrointestinal Therapeutics Business (2015-2020)
13.8.5 F. Hoffmann-La Roche Recent Development
13.9 Eli Lilly
13.9.1 Eli Lilly Company Details
13.9.2 Eli Lilly Business Overview
13.9.3 Eli Lilly Gastrointestinal Therapeutics Introduction
13.9.4 Eli Lilly Revenue in Gastrointestinal Therapeutics Business (2015-2020)
13.9.5 Eli Lilly Recent Development
13.10 AstraZeneca
13.10.1 AstraZeneca Company Details
13.10.2 AstraZeneca Business Overview
13.10.3 AstraZeneca Gastrointestinal Therapeutics Introduction
13.10.4 AstraZeneca Revenue in Gastrointestinal Therapeutics Business (2015-2020)
13.10.5 AstraZeneca Recent Development
13.11 Procter & Gamble
10.11.1 Procter & Gamble Company Details
10.11.2 Procter & Gamble Business Overview
10.11.3 Procter & Gamble Gastrointestinal Therapeutics Introduction
10.11.4 Procter & Gamble Revenue in Gastrointestinal Therapeutics Business (2015-2020)
10.11.5 Procter & Gamble Recent Development
13.12 Tillotts Pharma
10.12.1 Tillotts Pharma Company Details
10.12.2 Tillotts Pharma Business Overview
10.12.3 Tillotts Pharma Gastrointestinal Therapeutics Introduction
10.12.4 Tillotts Pharma Revenue in Gastrointestinal Therapeutics Business (2015-2020)
10.12.5 Tillotts Pharma Recent Development
13.13 Takeda
10.13.1 Takeda Company Details
10.13.2 Takeda Business Overview
10.13.3 Takeda Gastrointestinal Therapeutics Introduction
10.13.4 Takeda Revenue in Gastrointestinal Therapeutics Business (2015-2020)
10.13.5 Takeda Recent Development
13.14 GlaxoSmithKline
10.14.1 GlaxoSmithKline Company Details
10.14.2 GlaxoSmithKline Business Overview
10.14.3 GlaxoSmithKline Gastrointestinal Therapeutics Introduction
10.14.4 GlaxoSmithKline Revenue in Gastrointestinal Therapeutics Business (2015-2020)
10.14.5 GlaxoSmithKline Recent Development
13.15 Amgen
10.15.1 Amgen Company Details
10.15.2 Amgen Business Overview
10.15.3 Amgen Gastrointestinal Therapeutics Introduction
10.15.4 Amgen Revenue in Gastrointestinal Therapeutics Business (2015-2020)
10.15.5 Amgen Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of TablesTable 1. Gastrointestinal Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Gastrointestinal Therapeutics Revenue
Table 3. Ranking of Global Top Gastrointestinal Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Gastrointestinal Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Oral
Table 6. Key Players of Parenteral
Table 7. Global Gastrointestinal Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Gastrointestinal Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Gastrointestinal Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Gastrointestinal Therapeutics Market Share by Regions (2015-2020)
Table 11. Global Gastrointestinal Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Gastrointestinal Therapeutics Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Gastrointestinal Therapeutics Market Growth Strategy
Table 17. Main Points Interviewed from Key Gastrointestinal Therapeutics Players
Table 18. Global Gastrointestinal Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 19. Global Gastrointestinal Therapeutics Market Share by Players (2015-2020)
Table 20. Global Top Gastrointestinal Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gastrointestinal Therapeutics as of 2019)
Table 21. Global Gastrointestinal Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Gastrointestinal Therapeutics Product Solution and Service
Table 24. Date of Enter into Gastrointestinal Therapeutics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Gastrointestinal Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 27. Global Gastrointestinal Therapeutics Market Size Share by Type (2015-2020)
Table 28. Global Gastrointestinal Therapeutics Revenue Market Share by Type (2021-2026)
Table 29. Global Gastrointestinal Therapeutics Market Size Share by Application (2015-2020)
Table 30. Global Gastrointestinal Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 31. Global Gastrointestinal Therapeutics Market Size Share by Application (2021-2026)
Table 32. North America Key Players Gastrointestinal Therapeutics Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Gastrointestinal Therapeutics Market Share (2019-2020)
Table 34. North America Gastrointestinal Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 35. North America Gastrointestinal Therapeutics Market Share by Type (2015-2020)
Table 36. North America Gastrointestinal Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 37. North America Gastrointestinal Therapeutics Market Share by Application (2015-2020)
Table 38. Europe Key Players Gastrointestinal Therapeutics Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Gastrointestinal Therapeutics Market Share (2019-2020)
Table 40. Europe Gastrointestinal Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Gastrointestinal Therapeutics Market Share by Type (2015-2020)
Table 42. Europe Gastrointestinal Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Gastrointestinal Therapeutics Market Share by Application (2015-2020)
Table 44. China Key Players Gastrointestinal Therapeutics Revenue (2019-2020) (Million US$)
Table 45. China Key Players Gastrointestinal Therapeutics Market Share (2019-2020)
Table 46. China Gastrointestinal Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 47. China Gastrointestinal Therapeutics Market Share by Type (2015-2020)
Table 48. China Gastrointestinal Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 49. China Gastrointestinal Therapeutics Market Share by Application (2015-2020)
Table 50. Japan Key Players Gastrointestinal Therapeutics Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Gastrointestinal Therapeutics Market Share (2019-2020)
Table 52. Japan Gastrointestinal Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Gastrointestinal Therapeutics Market Share by Type (2015-2020)
Table 54. Japan Gastrointestinal Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Gastrointestinal Therapeutics Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Gastrointestinal Therapeutics Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Gastrointestinal Therapeutics Market Share (2019-2020)
Table 58. Southeast Asia Gastrointestinal Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Gastrointestinal Therapeutics Market Share by Type (2015-2020)
Table 60. Southeast Asia Gastrointestinal Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Gastrointestinal Therapeutics Market Share by Application (2015-2020)
Table 62. India Key Players Gastrointestinal Therapeutics Revenue (2019-2020) (Million US$)
Table 63. India Key Players Gastrointestinal Therapeutics Market Share (2019-2020)
Table 64. India Gastrointestinal Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 65. India Gastrointestinal Therapeutics Market Share by Type (2015-2020)
Table 66. India Gastrointestinal Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 67. India Gastrointestinal Therapeutics Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Gastrointestinal Therapeutics Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Gastrointestinal Therapeutics Market Share (2019-2020)
Table 70. Central & South America Gastrointestinal Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Gastrointestinal Therapeutics Market Share by Type (2015-2020)
Table 72. Central & South America Gastrointestinal Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Gastrointestinal Therapeutics Market Share by Application (2015-2020)
Table 74. AbbVie Company Details
Table 75. AbbVie Business Overview
Table 76. AbbVie Product
Table 77. AbbVie Revenue in Gastrointestinal Therapeutics Business (2015-2020) (Million US$)
Table 78. AbbVie Recent Development
Table 79. Allergan Company Details
Table 80. Allergan Business Overview
Table 81. Allergan Product
Table 82. Allergan Revenue in Gastrointestinal Therapeutics Business (2015-2020) (Million US$)
Table 83. Allergan Recent Development
Table 84. Johnson & Johnson Company Details
Table 85. Johnson & Johnson Business Overview
Table 86. Johnson & Johnson Product
Table 87. Johnson & Johnson Revenue in Gastrointestinal Therapeutics Business (2015-2020) (Million US$)
Table 88. Johnson & Johnson Recent Development
Table 89. Takeda Company Details
Table 90. Takeda Business Overview
Table 91. Takeda Product
Table 92. Takeda Revenue in Gastrointestinal Therapeutics Business (2015-2020) (Million US$)
Table 93. Takeda Recent Development
Table 94. Novartis Company Details
Table 95. Novartis Business Overview
Table 96. Novartis Product
Table 97. Novartis Revenue in Gastrointestinal Therapeutics Business (2015-2020) (Million US$)
Table 98. Novartis Recent Development
Table 99. Pfizer Company Details
Table 100. Pfizer Business Overview
Table 101. Pfizer Product
Table 102. Pfizer Revenue in Gastrointestinal Therapeutics Business (2015-2020) (Million US$)
Table 103. Pfizer Recent Development
Table 104. Merck Company Details
Table 105. Merck Business Overview
Table 106. Merck Product
Table 107. Merck Revenue in Gastrointestinal Therapeutics Business (2015-2020) (Million US$)
Table 108. Merck Recent Development
Table 109. F. Hoffmann-La Roche Business Overview
Table 110. F. Hoffmann-La Roche Product
Table 111. F. Hoffmann-La Roche Company Details
Table 112. F. Hoffmann-La Roche Revenue in Gastrointestinal Therapeutics Business (2015-2020) (Million US$)
Table 113. F. Hoffmann-La Roche Recent Development
Table 114. Eli Lilly Company Details
Table 115. Eli Lilly Business Overview
Table 116. Eli Lilly Product
Table 117. Eli Lilly Revenue in Gastrointestinal Therapeutics Business (2015-2020) (Million US$)
Table 118. Eli Lilly Recent Development
Table 119. AstraZeneca Company Details
Table 120. AstraZeneca Business Overview
Table 121. AstraZeneca Product
Table 122. AstraZeneca Revenue in Gastrointestinal Therapeutics Business (2015-2020) (Million US$)
Table 123. AstraZeneca Recent Development
Table 124. Procter & Gamble Company Details
Table 125. Procter & Gamble Business Overview
Table 126. Procter & Gamble Product
Table 127. Procter & Gamble Revenue in Gastrointestinal Therapeutics Business (2015-2020) (Million US$)
Table 128. Procter & Gamble Recent Development
Table 129. Tillotts Pharma Company Details
Table 130. Tillotts Pharma Business Overview
Table 131. Tillotts Pharma Product
Table 132. Tillotts Pharma Revenue in Gastrointestinal Therapeutics Business (2015-2020) (Million US$)
Table 133. Tillotts Pharma Recent Development
Table 134. Takeda Company Details
Table 135. Takeda Business Overview
Table 136. Takeda Product
Table 137. Takeda Revenue in Gastrointestinal Therapeutics Business (2015-2020) (Million US$)
Table 138. Takeda Recent Development
Table 139. GlaxoSmithKline Company Details
Table 140. GlaxoSmithKline Business Overview
Table 141. GlaxoSmithKline Product
Table 142. GlaxoSmithKline Revenue in Gastrointestinal Therapeutics Business (2015-2020) (Million US$)
Table 143. GlaxoSmithKline Recent Development
Table 144. Amgen Company Details
Table 145. Amgen Business Overview
Table 146. Amgen Product
Table 147. Amgen Revenue in Gastrointestinal Therapeutics Business (2015-2020) (Million US$)
Table 148. Amgen Recent Development
Table 149. Research Programs/Design for This Report
Table 150. Key Data Information from Secondary Sources
Table 151. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Gastrointestinal Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Oral Features
Figure 3. Parenteral Features
Figure 4. Global Gastrointestinal Therapeutics Market Share by Application: 2020 VS 2026
Figure 5. IBD Case Studies
Figure 6. Irritable Bowel Syndrome (IBS) Case Studies
Figure 7. Gastrointestinal Therapeutics Report Years Considered
Figure 8. Global Gastrointestinal Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 9. Global Gastrointestinal Therapeutics Market Share by Regions: 2020 VS 2026
Figure 10. Global Gastrointestinal Therapeutics Market Share by Regions (2021-2026)
Figure 11. Porter's Five Forces Analysis
Figure 12. Global Gastrointestinal Therapeutics Market Share by Players in 2019
Figure 13. Global Top Gastrointestinal Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gastrointestinal Therapeutics as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Gastrointestinal Therapeutics Revenue in 2019
Figure 15. North America Gastrointestinal Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 16. Europe Gastrointestinal Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. China Gastrointestinal Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Japan Gastrointestinal Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Southeast Asia Gastrointestinal Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. India Gastrointestinal Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Central & South America Gastrointestinal Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Bottom-up and Top-down Approaches for This Report
Figure 23. Data Triangulation
Figure 24. Key Executives Interviewed